Walgreens Boots drops on report Sycamore deal unlikely to have premium

 Walgreens Boots (NASDAQ:WBA) fell 4.7% after a report that a Sycamore Partners deal for the drugstore chain is unlikely to have much of a premium.

Sycamore is closing in on a deal for Walgreens (NASDAQ:WBA), though it's unlikely to have a premium to Walgreen's current price, CNBC's David Faber said on Friday, citing people familiar with the matter. 

"You may not get anything that involves a premium," Faber said on the business network. "Don't expect that it's going to be higher than here."

The update comes after the Financial Times on Thursday reported that Sycamore Partners plans to break the company into three separate pieces after taking the entire company private. 

https://www.msn.com/en-us/money/topstocks/walgreens-boots-drops-on-report-sycamore-deal-unlikely-to-have-premium/ar-AA1zZG7y